Daniel Chang, M.D.
■Stereotactic body radiotherapy for liver tumors
■Image-guided radiotherapy for GI cancers
■Normal tissue tolerance and toxicity associated with radiotherapy for GI cancers
■Predictive biomarkers for treatment response, toxicity, and outcome